Pasithea Therapeutics Corp. (NASDAQ: KTTA)
$5.86
-0.2000 ( -3.30% ) 4.2K
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia.
Market Data
Open
$5.86
Previous close
$6.06
Volume
4.2K
Market cap
$6.18M
Day range
$5.82 - $6.11
52 week range
$4.74 - $17.40
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Mar 01, 2024 |
8-k | 8K-related | 13 | Jan 18, 2024 |
8-k | 8K-related | 17 | Jan 02, 2024 |
8-k | 8K-related | 14 | Dec 28, 2023 |
8-k | 8K-related | 14 | Dec 19, 2023 |
10-q | Quarterly Reports | 66 | Nov 13, 2023 |
ars | Annual reports | 1 | Oct 26, 2023 |
def | Proxies and info statements | 4 | Oct 26, 2023 |
pre | Proxies and info statements | 4 | Oct 16, 2023 |
8-k | 8K-related | 13 | Oct 13, 2023 |